Home
/
Pulmonx Corp
/
Financials
/
Quarterly
Pulmonx Corp — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Pulmonx Corp filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$21.50M
Nov 12, 2025
Q2
2025
Jun 30, 2025
$23.86M
Aug 1, 2025
Q1
2025
Mar 31, 2025
$22.54M
May 2, 2025
Q3
2025
Sep 30, 2024
$20.39M
Nov 12, 2025
Q2
2025
Jun 30, 2024
$20.78M
Aug 1, 2025
Q1
2025
Mar 31, 2024
$18.85M
May 2, 2025
Q3
2024
Sep 30, 2023
$17.67M
Nov 1, 2024
Q2
2024
Jun 30, 2023
$17.19M
Aug 2, 2024
Q1
2024
Mar 31, 2023
$14.54M
May 3, 2024
Q3
2023
Sep 30, 2022
$13.50M
Nov 3, 2023
Q2
2023
Jun 30, 2022
$13.95M
Aug 4, 2023
Q1
2023
Mar 31, 2022
$10.79M
May 8, 2023
Q3
2022
Sep 30, 2021
$13.26M
Nov 8, 2022
Q2
2022
Jun 30, 2021
$12.20M
Aug 8, 2022
Q1
2022
Mar 31, 2021
$9.24M
May 9, 2022
Q3
2021
Sep 30, 2020
$10.61M
Nov 9, 2021
Q2
2021
Jun 30, 2020
$3.67M
Aug 10, 2021
Q1
2021
Mar 31, 2020
$8.62M
May 12, 2021
Q3
2020
Sep 30, 2019
$9.10M
Nov 13, 2020
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($13.96M)
Nov 12, 2025
Q2
2025
Jun 30, 2025
($15.17M)
Aug 1, 2025
Q3
2025
Jun 30, 2025
($15.17M)
Nov 12, 2025
Q1
2025
Mar 31, 2025
($14.45M)
May 2, 2025
Q2
2025
Mar 31, 2025
($14.45M)
Aug 1, 2025
Q3
2025
Mar 31, 2025
($14.45M)
Nov 12, 2025
Q3
2025
Sep 30, 2024
($14.14M)
Nov 12, 2025
Q3
2025
Jun 30, 2024
($15.33M)
Nov 12, 2025
Q2
2025
Jun 30, 2024
($15.33M)
Aug 1, 2025
Q2
2025
Mar 31, 2024
($13.75M)
Aug 1, 2025
Q1
2025
Mar 31, 2024
($13.75M)
May 2, 2025
Q3
2025
Mar 31, 2024
($13.75M)
Nov 12, 2025
Q3
2024
Sep 30, 2023
($14.90M)
Nov 1, 2024
Q2
2024
Jun 30, 2023
($16.20M)
Aug 2, 2024
Q3
2024
Jun 30, 2023
($16.20M)
Nov 1, 2024
Q3
2024
Mar 31, 2023
($15.86M)
Nov 1, 2024
Q1
2024
Mar 31, 2023
($15.86M)
May 3, 2024
Q2
2024
Mar 31, 2023
($15.86M)
Aug 2, 2024
Q3
2023
Sep 30, 2022
($14.17M)
Nov 3, 2023
Q2
2023
Jun 30, 2022
($14.64M)
Aug 4, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($14.39M)
Nov 12, 2025
Q2
2025
Jun 30, 2025
($14.80M)
Aug 1, 2025
Q1
2025
Mar 31, 2025
($14.56M)
May 2, 2025
Q3
2025
Sep 30, 2024
($14.13M)
Nov 12, 2025
Q2
2025
Jun 30, 2024
($15.62M)
Aug 1, 2025
Q1
2025
Mar 31, 2024
($14.54M)
May 2, 2025
Q3
2024
Sep 30, 2023
($15.18M)
Nov 1, 2024
Q2
2024
Jun 30, 2023
($16.44M)
Aug 2, 2024
Q1
2024
Mar 31, 2023
($16.40M)
May 3, 2024
Q3
2023
Sep 30, 2022
($13.93M)
Nov 3, 2023
Q2
2023
Jun 30, 2022
($14.41M)
Aug 4, 2023
Q1
2023
Mar 31, 2022
($15.67M)
May 8, 2023
Q3
2022
Sep 30, 2021
($9.76M)
Nov 8, 2022
Q2
2022
Jun 30, 2021
($12.68M)
Aug 8, 2022
Q3
2021
Jun 30, 2021
($12.68M)
Nov 9, 2021
Q1
2022
Mar 31, 2021
($12.49M)
May 9, 2022
Q3
2021
Mar 31, 2021
($12.49M)
Nov 9, 2021
Q3
2021
Sep 30, 2020
($5.35M)
Nov 9, 2021
Q2
2021
Jun 30, 2020
($11.53M)
Aug 10, 2021
Q1
2021
Mar 31, 2020
($6.10M)
May 12, 2021